Severe	severe	O	O	O	O
thrombocytopenia	thrombocytopenia	O	DISEASE	OTHERS	I
and	and	O	O	O	O
haemolytic	haemolytic	O	O	OTHERS	I
anaemia	anaemia	O	O	OTHERS	I
associated	associated	O	O	O	O
with	with	O	O	O	O
ciprofloxacin	ciprofloxacin	CHEMICALS	O	OTHERS	I
:	:	O	O	O	O
a	a	O	O	O	O
case	case	O	O	O	O
report	report	O	O	O	O
with	with	O	O	O	O
fatal	fatal	O	O	O	O
outcome	outcome	O	O	O	O
.	.	O	O	O	O

Haematological	haematological	O	O	O	O
adverse	adverse	O	O	O	O
reactions	reactions	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
fatal	fatal	O	O	O	O
outcome	outcome	O	O	O	O
are	are	O	O	O	O
rare	rare	O	O	O	O
during	during	O	O	O	O
treatment	treatment	O	O	O	O
with	with	O	O	O	O
ciprofloxacin	ciprofloxacin	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

A	a	O	O	O	O
30-year	30-year	O	O	O	O
old	old	O	O	O	O
Caucasian	caucasian	O	O	O	O
man	man	O	O	O	O
reported	reported	O	O	O	O
with	with	O	O	O	O
abdominal	abdominal	O	DISEASE	OTHERS	I
pain	pain	O	DISEASE	OTHERS	I
and	and	O	O	O	O
jaundice	jaundice	O	DISEASE	OTHERS	I
after	after	O	O	O	O
3-day	3-day	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
oral	oral	O	O	O	O
ciprofloxacin	ciprofloxacin	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
a	a	O	O	O	O
suspect	suspect	O	O	O	O
of	of	O	O	O	O
urinary	urinary	O	DISEASE	OTHERS	I
tract	tract	O	DISEASE	OTHERS	I
infection	infection	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Clinical	clinical	O	O	O	O
evaluations	evaluations	O	O	O	O
suggested	suggested	O	O	O	O
an	an	O	O	O	O
initial	initial	O	O	O	O
diagnosis	diagnosis	O	O	O	O
of	of	O	O	O	O
severe	severe	O	O	O	O
thrombocytopenia	thrombocytopenia	O	DISEASE	OTHERS	I
and	and	O	O	O	O
haemolysis	haemolysis	O	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
patient	patient	O	O	O	O
progressively	progressively	O	O	O	O
developed	developed	O	O	O	O
petechiae	petechiae	O	O	OTHERS	I
and	and	O	O	O	O
purpura	purpura	O	O	OTHERS	I
on	on	O	O	O	O
thorax	thorax	O	O	O	O
and	and	O	O	O	O
lower	lower	O	O	O	O
limbs	limbs	O	O	O	O
.	.	O	O	O	O

Despite	despite	O	O	O	O
pharmacological	pharmacological	O	O	O	O
and	and	O	O	O	O
supportive	supportive	O	O	O	O
interventions	interventions	O	O	O	O
,	,	O	O	O	O
laboratory	laboratory	O	O	O	O
parameters	parameters	O	O	O	O
worsened	worsened	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
died	died	O	O	O	O
17	17	O	O	O	O
hours	hours	O	O	O	O
after	after	O	O	O	O
admission	admission	O	O	O	O
.	.	O	O	O	O

An	an	O	O	O	O
accurate	accurate	O	O	O	O
autopsy	autopsy	O	O	O	O
revealed	revealed	O	O	O	O
most	most	O	O	O	O
organs	organs	O	O	O	O
with	with	O	O	O	O
diffuse	diffuse	O	O	O	O
petechial	petechial	O	O	O	O
haemorrhages	haemorrhages	O	O	OTHERS	I
.	.	O	O	O	O

No	no	O	O	O	O
signs	signs	O	O	O	O
of	of	O	O	O	O
bone	bone	O	O	OTHERS	I
marrow	marrow	O	O	OTHERS	I
depression	depression	O	DISEASE	OTHERS	I
were	were	O	O	O	O
found	found	O	O	O	O
.	.	O	O	O	O

No	no	O	O	O	O
thrombi	thrombi	O	DISEASE	OTHERS	I
or	or	O	O	O	O
signs	signs	O	O	O	O
of	of	O	O	O	O
microangiopathies	microangiopathies	O	O	OTHERS	I
were	were	O	O	O	O
observed	observed	O	O	O	O
in	in	O	O	O	O
arterial	arterial	O	O	O	O
vessels	vessels	O	O	O	O
.	.	O	O	O	O

Blood	blood	O	O	O	O
and	and	O	O	O	O
urine	urine	O	O	O	O
cultures	cultures	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
show	show	O	O	O	O
any	any	O	O	O	O
bacterial	bacterial	O	O	O	O
growth	growth	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
case	case	O	O	O	O
report	report	O	O	O	O
shows	shows	O	O	O	O
that	that	O	O	O	O
ciprofloxacin	ciprofloxacin	CHEMICALS	O	OTHERS	I
may	may	O	O	O	O
precipitate	precipitate	O	O	O	O
life-threatening	life-threatening	O	O	O	O
thrombocytopenia	thrombocytopenia	O	DISEASE	OTHERS	I
and	and	O	O	O	O
haemolytic	haemolytic	O	O	OTHERS	I
anaemia	anaemia	O	O	OTHERS	I
,	,	O	O	O	O
even	even	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
early	early	O	O	O	O
phases	phases	O	O	O	O
of	of	O	O	O	O
treatment	treatment	O	O	O	O
and	and	O	O	O	O
without	without	O	O	O	O
apparent	apparent	O	O	O	O
previous	previous	O	O	O	O
exposures	exposures	O	O	O	O
.	.	O	O	O	O

